EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Characterization of T-Cell Receptor Profiles Predicts Survival Situation in Patients with Hepatocellular Carcinoma

Fengyan Wang, Li Deng, Ziqiang Li, Qiwei Cao, Runze Jiang iD, Changqing Xu, Jing Yang

Technology in Cancer Research & Treatment · 2025

DOI: 10.1177/15330338251329699 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2025. Verfasst von Fengyan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Receptors, Antigen, T-Cell, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Technology Research and Development Project of Shandong Province, National Natural Science Foundation of China, Medical and Health Technology Development Program of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Hepatocellular carcinoma (HCC) is the most common liver malignancy in the world, and tumor-infiltrating T cells have been shown to be closely related to the prognosis of HCC. This study investigated the potential and efficacy of T cell receptor (TCR) repertoire characterization as a biomarker for predicting survival differences.

Methods

In this study, we used high-throughput sequencing technology to systematically analyze the characteristics of TCR repertoires in tumor tissues obtained from 23 long-survivors and 8 short-survivors diagnosed with HCC.

Results

The TCR composition in HCC long-survivors was found to be less diverse than in the short-survivors. In addition, in the context of V and J gene segments, long-survivors showed significantly higher usage of TRBJ1-3, TRBV10-1, TRBV15, and TRBV6-5, and lower usage of TRBJ2-2. Both principal component analysis (PCA) and the motif diagram of complementary determination region 3 (CDR3) sequences could clearly discriminate short- and long-survivors. And there were five up-regulated and one down-regulated CDR3 sequences in the LS group compared with the SS group. According to the characteristics of TCR repertoire, we also established the survival-related evaluation system and the prediction model for the survival period of HCC patients.

Conclusion

Our study adds to the existing knowledge of TCR rearrangement profiles in HCC patients by elucidating the differential TCR rearrangement profiles between long-term and short-term surviving HCC patients. Also, our analysis identified a number of TCR genes that are significantly associated with survival, and these may not only serve as prognostic biomarkers but may also play an important role in antigen-specific immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsReceptors, Antigen, T-CellBiomarkers, TumorHumansPrognosisMaleFemaleMiddle AgedAgedHigh-Throughput Nucleotide SequencingComplementarity Determining Regions

Stichwörter der Autor:innen

T-cell receptor (TCR) repertoirehepatocellular carcinoma (HCC)high-throughput sequencing (HTS)immunotherapyprognostic biomarker

Substanzen

Receptors, Antigen, T-CellBiomarkers, TumorComplementarity Determining Regions

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
  • Shandong Provincial Key Laboratory of Neuroprotective Drugs, Zibo, China.
  • Department of General Surgery, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
  • Department of Pathology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Clinical Pathology, Shandong Lung Can…
  • Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.

ORCID-Profile: Runze Jiang

Förderung

  • Technology Research and Development Project of Shandong Province
  • National Natural Science Foundation of China
  • Medical and Health Technology Development Program of Shandong Province
  • Shandong Provincial Integrated Traditional Chinese and Western Medicine Special Disease Prevention Project
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Wang, F., Deng, L., Li, Z., Cao, Q., Jiang, R., Xu, C., & Yang, J. (2025). Characterization of T-Cell Receptor Profiles Predicts Survival Situation in Patients with Hepatocellular Carcinoma. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338251329699

Vancouver

Wang F, Deng L, Li Z, Cao Q, Jiang R, Xu C, et al. Characterization of T-Cell Receptor Profiles Predicts Survival Situation in Patients with Hepatocellular Carcinoma. Technology in Cancer Research & Treatment. 2025. doi:10.1177/15330338251329699

BibTeX
@article{Wang2025,
  author = {Wang, Fengyan and Deng, Li and Li, Ziqiang and Cao, Qiwei and Jiang, Runze and Xu, Changqing and Yang, Jing},
  title = {Characterization of T-Cell Receptor Profiles Predicts Survival Situation in Patients with Hepatocellular Carcinoma},
  journal = {Technology in Cancer Research & Treatment},
  year = {2025},
  doi = {10.1177/15330338251329699}
}
Kostenlos starten →